Produktinformation
- [1aR-(1aR*,3S*,4S*,6Z,9S*,15bR*)]-1a,8,9,15b-Tetrahydro-3,4,12-trihydroxy-14-methoxy-9-methyl-3H-oxireno[k][2]benzoxacyclotetradecin-5,11(2H,4H)-dione
- NSC 354462
- f 152 D2
Applications Hypothemycin is a potent and selective inhibitor of threonine/tyrosine-specific kinase, MEK, and other protein kinases that contain a conserved cysteine residue in the ATP-binding site in in vitro studies.
References Zhao, A., et al.: J. Antibiotics, 52, 1086 (1999); Schirmer, A., et al.: Proc. Nat. Acad. Sci. U. S. A., 103, 4234 (2006); Winssinger, M., et al.: Chem. Comm., 1, 22 (2007)